XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies
Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic…
XTL Biopharmaceuticals Announces ADS Ratio Change
March 20, 2026 16:10 ET | Source: XTL Biopharmaceuticals Ltd. RAMAT GAN,…
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
December 24, 2025 16:00 ET | Source: XTL Biopharmaceuticals Ltd. RAMAT GAN,…
